HIV_AIDS

0047
(NQF #0326)
Care Plan
National Quality Strategy Domain: Communication and Care Coordination
Was advance care plan or surrogate decision maker documented in the medical record?
If patient’s cultural and/or spiritual beliefs preclude a discussion of advance care planning, report 1124F.

Advanced care planning discussed and documented.
(1123F) (Performance Met)
1123F

Advanced care planning discussed and documented; patient did not wish or was not able to name a surrogate decision marker or provide an advance care plan, or patient’s cultural and/or spiritual beliefs preclude a discussion of advance care planning.
(1124F) (Performance Met)
1124F

Advance care planning not documented, reason not otherwise specified.
(1123F:8P) (Performance Not Met)
1123F:8P
X
y
y

0134
(NQF 0418)
Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
National Quality Strategy Domain: Community/Population Health
Was patient screened for clinical depression with a standard screening tool AND if positive, a follow-up plan is documented.
Patients aged 12 and older screened for depression with a follow-up plan on the date of the encounter.

Screening for clinical depression is documented as being positive AND a follow-up plan is documented.
(G8431) (Performance Met)
G8431

Screening for clinical depression is documented as negative, a follow-up plan is not required.
(G8510) (Performance Met)
G8510

Screening for clinical depression not documented, documentation stating the patient is not eligible.
(G8433) (Other Performance Exclusion)
G8433

Screening for clinical depression documented as positive, a follow-up plan not documented, documentation stating the patient is not eligible
(G8940) (Other Performance Exclusion)
G8940

Clinical depression screening not documented, reason not given.
(G8432) (Performance Not Met)
G8432

Screening for clinical depression documented as positive, follow-up plan not documented, reason not given.
(G8511) (Performance Not Met)
G8511
X
y
y


0160
(NQF #0405)
HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
National Quality Strategy Domain: Effective Clinical Care
Was patient prescribed pneumocystis jiroveci pneumonia (PCP) prophylaxis within 3 months of CD4 count below 200 cells/mm3?
May include prescription given to the patient for PCP prophylaxis therapy at one or more visits in the 12-month period OR patient already taking PCP prophylaxis therapy as documented in current medication list.

Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low CD4+ cell count below 200 cells/mm3.\\nAND CD4+ cell count < 200 cells/mm3.
(G9222, 3494F) (Performance Met)
G9222 3494F


Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low CD4+ cell count below 200 cells/mm3 for medical reason (i.e., patient’s CD4+ cell count above threshold within 3 months after CD4+ cell count below threshold, indicating that the patient’s CD4+ levels are within an acceptable range and the patient does not require PCP prophylaxis).\\nAND CD4+ cell count < 200 cells/mm3.
(G9219, 3494F) (Medical Performance Exclusion)
G9219 3494F

CD4+ cell count 200 – 499 cells/mm3.
(3495F) (Other Performance Exclusion)
3495F

CD4+ cell count = 500 cells/mm3.
(3496F) (Other Performance Exclusion)
3496F

PCP prophylaxis was not prescribed within 3 months of low CD4+ cell count below 200 cells/mm3, reason not given.\\nAND CD4+ cell count < 200 cells/mm3.
(G9217, 3494F) (Performance Not Met)
G9217 3494F

CD4+ cell count not performed, reason not otherwise specified.
(3494F:8P) (Performance Not Met)
3494F:8P
X
y
y

0205
(NQF #0409)
HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis
National Quality Strategy Domain: Effective Clinical Care
Was patient screened for chlamydia, gonorrhea, and syphilis at least once since the diagnosis of HIV infection?
.
Chlamydia, gonorrhea, and syphilis screening results documented (report when results are present for all of the 3 screenings).
(G9228) (Performance Met)
G9228

Chlamydia, gonorrhea, and syphilis screening results not documented (Patient refusal is the only allowed exclusion).
(G9229) (Other Performance Exclusion)
G9229

Chlamydia, gonorrhea, and syphilis screening not documented as performed, reason not otherwise specified.
(G9230) (Performance Not Met)
G9230
X
y
y

0226
(NQF #0028)
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
National Quality Strategy Domain: Community / Population Health
Was patient screened for tobacco use within 24 months AND given tobacco cessation interventionn//nif identified as a tobacco user?
Tobacco Use – Includes use of any type of tobacco; Tobacco Cessation Intervention – Includes brief//n counseling (3 minutes or less), and/or pharmacotherapy.
Patient Screened for Tobacco Use, Identified as a User and Received Intervention
(4004F) (Performance Met)
4004F
Patient Screened for Tobacco Use and Identified as a Non-User of Tobacco
(1036F) (Performance Met)
1036F
Tobacco Screening not Performed for Medical Reasons
(4004F:1P) Medical Performance Exclusion
4004F:1P
Tobacco Screening OR Tobacco Cessation Intervention not Performed, Reason Not Otherwise Specified
(4004F:8P) (Performance Not Met)
4004F:8P
X
y
y

0338
(NQF #2082)

HIV Viral Load Suppression
National Quality Strategy Domain: Effective Clinical Care

Was patient's HIV viral load less than 200 copies/mL at last viral load test?
.

Documentation of viral load less than 200 copies/mL.
(G9243) (Performance Met)
G9243

Documentation of viral load equal to or greater than 200 copies/mL or viral load not performed.
(G9242) (Performance Not Met)
G9242

X
y
y

0339
(NQF #2083)
Prescription of HIV Antiretroviral Therapy
National Quality Strategy Domain: Effective Clinical Care
Was patient prescribed HIV antiretroviral therapy during the reporting period?
HIV antiretroviral therapy is described as the prescription of at least one U.S. Food and Drug Administration approved HIV antiretroviral medication.
Antiretroviral therapy prescribed.
(G9245) (Performance Met)
G9245

Antiretroviral therapy not prescribed.
(G9244) (Performance Not Met)
G9244
X
y
y

0340
(NQF #2079)
HIV Medical Visit Frequency
National Quality Strategy Domain: Efficiency And Cost Reduction
Did patient have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits?
.
Patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits.
(G9247) (Performance Met)
G9247

Patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits.
(G9246) (Performance Not Met)
G9246

X
y
n
